These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

577 related articles for article (PubMed ID: 10674382)

  • 21. Utility of Horizontal Sections of Scalp Biopsies in Differentiating between Androgenetic Alopecia and Alopecia Areata.
    Yadav D; Khandpur S; Ramam M; Singh MK; Sharma VK
    Dermatology; 2018; 234(3-4):137-147. PubMed ID: 30092597
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Changes in hair weight in men with androgenetic alopecia after treatment with finasteride (1 mg daily): three- and 4-year results.
    Price VH; Menefee E; Sanchez M; Kaufman KD
    J Am Acad Dermatol; 2006 Jul; 55(1):71-4. PubMed ID: 16781295
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hair counts from scalp biopsy specimens in Asians.
    Lee HJ; Ha SJ; Lee JH; Kim JW; Kim HO; Whiting DA
    J Am Acad Dermatol; 2002 Feb; 46(2):218-21. PubMed ID: 11807433
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hair loss in women: medical and cosmetic approaches to increase scalp hair fullness.
    Sinclair R; Patel M; Dawson TL; Yazdabadi A; Yip L; Perez A; Rufaut NW
    Br J Dermatol; 2011 Dec; 165 Suppl 3():12-8. PubMed ID: 22171680
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Follicular density and ratios in scarring and nonscarring alopecia.
    Horenstein MG; Bacheler CJ
    Am J Dermatopathol; 2013 Dec; 35(8):818-26. PubMed ID: 23435361
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Androgens and alopecia.
    Kaufman KD
    Mol Cell Endocrinol; 2002 Dec; 198(1-2):89-95. PubMed ID: 12573818
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The effects of finasteride on scalp skin and serum androgen levels in men with androgenetic alopecia.
    Drake L; Hordinsky M; Fiedler V; Swinehart J; Unger WP; Cotterill PC; Thiboutot DM; Lowe N; Jacobson C; Whiting D; Stieglitz S; Kraus SJ; Griffin EI; Weiss D; Carrington P; Gencheff C; Cole GW; Pariser DM; Epstein ES; Tanaka W; Dallob A; Vandormael K; Geissler L; Waldstreicher J
    J Am Acad Dermatol; 1999 Oct; 41(4):550-4. PubMed ID: 10495374
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The effectiveness of finasteride and dutasteride used for 3 years in women with androgenetic alopecia.
    Boersma IH; Oranje AP; Grimalt R; Iorizzo M; Piraccini BM; Verdonschot EH
    Indian J Dermatol Venereol Leprol; 2014; 80(6):521-5. PubMed ID: 25382509
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Global photographic assessment of men aged 18 to 60 years with male pattern hair loss receiving finasteride 1 mg or placebo.
    Olsen EA; Whiting DA; Savin R; Rodgers A; Johnson-Levonas AO; Round E; Rotonda J; Kaufman KD;
    J Am Acad Dermatol; 2012 Sep; 67(3):379-86. PubMed ID: 22325459
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Long-term (5-year) multinational experience with finasteride 1 mg in the treatment of men with androgenetic alopecia.
    Finasteride Male Pattern Hair Loss Study Group
    Eur J Dermatol; 2002; 12(1):38-49. PubMed ID: 11809594
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The expression of insulin-like growth factor 1 in follicular dermal papillae correlates with therapeutic efficacy of finasteride in androgenetic alopecia.
    Tang L; Bernardo O; Bolduc C; Lui H; Madani S; Shapiro J
    J Am Acad Dermatol; 2003 Aug; 49(2):229-33. PubMed ID: 12894070
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Finasteride in the treatment of men with frontal male pattern hair loss.
    Leyden J; Dunlap F; Miller B; Winters P; Lebwohl M; Hecker D; Kraus S; Baldwin H; Shalita A; Draelos Z; Markou M; Thiboutot D; Rapaport M; Kang S; Kelly T; Pariser D; Webster G; Hordinsky M; Rietschel R; Katz HI; Terranella L; Best S; Round E; Waldstreicher J
    J Am Acad Dermatol; 1999 Jun; 40(6 Pt 1):930-7. PubMed ID: 10365924
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Permanent alopecia after systemic chemotherapy: a clinicopathological study of 10 cases.
    Miteva M; Misciali C; Fanti PA; Vincenzi C; Romanelli P; Tosti A
    Am J Dermatopathol; 2011 Jun; 33(4):345-50. PubMed ID: 21430504
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Androgenetic alopecia in males: a histopathological and ultrastructural study.
    El-Domyati M; Attia S; Saleh F; Abdel-Wahab H
    J Cosmet Dermatol; 2009 Jun; 8(2):83-91. PubMed ID: 19527330
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The reliability of horizontally sectioned scalp biopsies in the diagnosis of chronic diffuse telogen hair loss in women.
    Sinclair R; Jolley D; Mallari R; Magee J
    J Am Acad Dermatol; 2004 Aug; 51(2):189-99. PubMed ID: 15280836
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Finasteride treatment of patterned hair loss in normoandrogenic postmenopausal women.
    Trüeb RM;
    Dermatology; 2004; 209(3):202-7. PubMed ID: 15459533
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A randomized, active- and placebo-controlled study of the efficacy and safety of different doses of dutasteride versus placebo and finasteride in the treatment of male subjects with androgenetic alopecia.
    Gubelin Harcha W; Barboza Martínez J; Tsai TF; Katsuoka K; Kawashima M; Tsuboi R; Barnes A; Ferron-Brady G; Chetty D
    J Am Acad Dermatol; 2014 Mar; 70(3):489-498.e3. PubMed ID: 24411083
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Possible mechanisms of miniaturization during androgenetic alopecia or pattern hair loss.
    Whiting DA
    J Am Acad Dermatol; 2001 Sep; 45(3 Suppl):S81-6. PubMed ID: 11511857
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Therapy of androgenetic alopecia with finasteride. What must be considered in consultation and drug prescribing].
    Wolff H; Kunte C
    MMW Fortschr Med; 1999 Sep; 141(37):38-40. PubMed ID: 10897972
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 29.